Skip to main content

Table 1 Inclusion and exclusion study criteria according to the protocol body text

From: Restoring Study PRGF: a randomized clinical trial on plasma rich in growth factors for knee osteoarthritis

Inclusion criteria

• Male and female adults aged 40–72 years

• Radiological diagnosis of tibiofemoral knee osteoarthritis

• Joint pain >35 mm, according to Visual Analogue Scale (range 0–100 mm)

• Radiological severity <4, according to the Ahlbäck scale (range 1–5)

• Body Mass Index between 20 and 30 a

• Availability to be examined along the follow-up period

Exclusion criteria

• Bilateral knee osteoarthritis needing infiltration in both knees

• Body Mass Index ≥30 b

• Diagnosis of polyarticular disease

• Severe mechanical deformity (bidiaphyseal varus 4° and valgus 16°)

• Previous arthroscopy within last year

• Hyaluronic acid infiltration within last 6 months

• Diagnosis of systemic autoimmune rheumatoid disease (connective tissue diseases and systemic necrotizing vasculitis)

• Uncontrolled diabetes mellitus (glycosylated haemoglobin >7%)

• Blood disorders (thrombopathy, thrombocytopenia, anaemia with haemoglobin <9)

• Ongoing immunosuppressive and/or dicumarinic therapies

• Use of corticosteroids within last 3 months before inclusion in study

• Use of non-steroidal anti-inflammatory drugs within the last 15 days before inclusion in the study

  1. aAccording to the summary of the protocol, final report and published article, body mass index between 20 and 32
  2. bAccording to the summary of the protocol, body mass index ≥32. According to the final report and published article, body mass index ≥33